- Home
- IKT vs MYPS Comparison
IKT vs MYPS Comparison
Compare IKT & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- MYPS
- Stock Information
- Founded
- IKT 2008
- MYPS 2011
- Country
- IKT United States
- MYPS United States
- Employees
- IKT N/A
- MYPS N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- MYPS EDP Services
- Sector
- IKT Health Care
- MYPS Technology
- Exchange
- IKT Nasdaq
- MYPS Nasdaq
- Market Cap
- IKT 140.5M
- MYPS 121.6M
- IPO Year
- IKT 2020
- MYPS N/A
- Fundamental
- Price
- IKT $1.66
- MYPS $0.97
- Analyst Decision
- IKT Buy
- MYPS Buy
- Analyst Count
- IKT 2
- MYPS 5
- Target Price
- IKT $8.00
- MYPS $2.50
- AVG Volume (30 Days)
- IKT 97.5K
- MYPS 242.9K
- Earning Date
- IKT 08-14-2025
- MYPS 11-03-2025
- Dividend Yield
- IKT N/A
- MYPS N/A
- EPS Growth
- IKT N/A
- MYPS N/A
- EPS
- IKT N/A
- MYPS N/A
- Revenue
- IKT N/A
- MYPS $261,058,000.00
- Revenue This Year
- IKT N/A
- MYPS N/A
- Revenue Next Year
- IKT N/A
- MYPS N/A
- P/E Ratio
- IKT N/A
- MYPS N/A
- Revenue Growth
- IKT N/A
- MYPS N/A
- 52 Week Low
- IKT $1.12
- MYPS $0.90
- 52 Week High
- IKT $4.20
- MYPS $2.29
- Technical
- Relative Strength Index (RSI)
- IKT 45.73
- MYPS 39.84
- Support Level
- IKT $1.66
- MYPS $0.94
- Resistance Level
- IKT $1.87
- MYPS $0.98
- Average True Range (ATR)
- IKT 0.10
- MYPS 0.04
- MACD
- IKT -0.01
- MYPS 0.01
- Stochastic Oscillator
- IKT 33.82
- MYPS 43.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.